C12Y 302/01169
Protein o-glcnacase
Official title: Protein O-GlcNAcase (3.2.1.169)
C12Y302/01169 (Protein o-glcnacase) appears on 5 US grants and 15 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 15
- Assignees
- 9
- Inventors
- 38
- Latest grant
- 19 Nov 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 3 |
By publication year.
Recent patents
- Glucose sensors and methods of use thereof19 Nov 2024US 12,146,883 B2Biocapital Holdings, LLC
- Engineered beta-glucosidases and glucosylation methods12 Apr 2022US 11,299,723 B2Codexis, Inc.
- Glycan-specific analytical tools27 Mar 2018US 9,926,612 B2Glycosensors and Diagnostics, LLC
- Glycosidase inhibitors and uses thereof7 Nov 2017US 9,809,537 B2Alectos Therapeutics Inc.
- Selective glycosidase inhibitors and uses thereof1 Aug 2017US 9,718,854 B2Alectos Therapeutics Inc.
- Methods for enhancing adoptive cell transfer immunotherapies23 Oct 2025US 2025/0325640 A1Hansa Biopharma AB
- Biological devices for the detection of alzheimer's disease and concussions and methods of use thereof17 Jul 2025US 2025/0231201 A1
- Glucose sensors and methods of use thereof30 Jan 2025US 2025/0035637 A1Biocapital Holdings, LLC
- Small-molecule-activated glycan modifying enzymes and uses thereof27 Jun 2024US 2024/0209334 A1President and Fellows of Harvard College
- Disaccharide linker, disaccharide-small molecule drug conjugate and sugar chain fixed-point antibody-drug conjugate, and preparation method therefor and use thereof20 Jun 2024US 2024/0197900 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Most cited
By later US patents